NCT02133482View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

Placebo

placebo solution

DRUG

BI 639667

oral solution BI 639667, single rising doses

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY